ÂÜÀòÂÒÂ×

Juan-Pablo Mas is a Partner at Action Potential Venture Capital, focusing on investments in Bioelectronic Medicines, Precision Diagnostics, and Computational Biology since August 2014. Additionally, Juan-Pablo serves as a Board Member at Onc.AI, Exo Imaging, Inc., Saluda Medical, Presidio Medical, Inc., SetPoint Medical, Gradient Denervation Technologies, and Cala Health, as well as a Board Observer at Neuspera Medical Inc. Active in the academic community, Juan-Pablo is part of the Translational Oversight Committee at the Stanford Wu Tsai Neurosciences Institute. Educational qualifications include an MBA from Stanford University Graduate School of Business, and both an MS and BS in Electrical Engineering from Stanford University and the University of Massachusetts Amherst, respectively, with a minor in Mathematics.